This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting enzyme inhibition or receptor modulation. Its structure, featuring a benzylcarbamoyl group and a hydrazinylacetic acid moiety, makes it suitable for designing molecules with potential therapeutic applications. Researchers often employ it in the development of new drugs, especially in areas like oncology, where it may be used to create inhibitors for specific cancer-related enzymes. Additionally, its hydrazine derivative properties make it valuable in the study of chemical reactions involving hydrazine-based compounds, contributing to advancements in drug discovery and optimization processes.